Fibroindex, a simple noninvasive test forprediction of fibrosis in patients withchronic hepatitis C virus infection

Non-invasive fibrosis markers and transient elastography versus liver biopsy as predictors for end treatment response in chronic HCV patients receiving pegylated interferon and ribavirin

Evaluation of serum fibrogenicmarkers in relation to histopathological findings inpatients with chronic hepatitis C

Evaluation of fibroscan as a predictor of risk of hepatocellular carcinoma in hepatitis C patients

Towards a scoring system depending on laboratory and ultrasound findingsfor the detection of hepatic fibrosis in chronic HCV infected patients

Metaanalysis of non invasive assessment of liver fibrosis :Applications and limitations

Comparative study between liver biopsy versus fibroscan in chronic hepatitis C virus patients

Role of transient elastography (fibroscan) in assessment of liver fibrosis in chronic hepatitis C patients

Biochemical markers of liver fibrosis in HCV patients

Evaluation of post interferon therapy changes in chronic HCV patients : Clinical, Doppler ultrasonography and histopathological study